Trial intelligence / Profile preview

Fenofibrate and Metformin in Type 2 Diabetes and Dyslipidemia

NCT00349128Phase 3Completed

Sponsor
Solvay
Start
Jan 2004
Modality
Small Molecules
Countries
3
01

Overview

A Phase 3 trial of fenofibrate in dyslipidemia, sponsored by Solvay. Started Jan 2004; status: completed.

02

Drugs

fenofibrate
03

Conditions

dyslipidemia

Beyond the preview

Go deeper on NCT00349128.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00349128.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call